Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)
China flag China · Delayed Price · Currency is CNY
55.61
-1.54 (-2.69%)
Nov 13, 2024, 3:00 PM CST

Shanghai Allist Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Cash & Equivalents
7171,862470.49615.36365.84392.58
Upgrade
Short-Term Investments
-230-20--
Upgrade
Trading Asset Securities
2,313419.61,5671,6252,225554.4
Upgrade
Cash & Short-Term Investments
3,0302,5122,0372,2602,591946.98
Upgrade
Cash Growth
34.35%23.29%-9.86%-12.78%173.64%636.30%
Upgrade
Accounts Receivable
347.09260.17150.8514.830.290.63
Upgrade
Other Receivables
2.5129.076.823.582.281.22
Upgrade
Receivables
349.59289.24157.6818.422.571.85
Upgrade
Inventory
38.8162.9532.0720.810.780.25
Upgrade
Prepaid Expenses
-3.182.5---
Upgrade
Other Current Assets
372.0740.7956.6975.4274.6936.75
Upgrade
Total Current Assets
3,7902,9082,2862,3752,679985.84
Upgrade
Property, Plant & Equipment
516.81526.64539.94404.03206.88138.16
Upgrade
Long-Term Investments
210.17145.2652.7338.3720110
Upgrade
Other Intangible Assets
65.8966.4968.4567.2969.1868.35
Upgrade
Long-Term Deferred Tax Assets
--11.5---
Upgrade
Long-Term Deferred Charges
157.650.710.572.112.71-
Upgrade
Other Long-Term Assets
692.43729.5482.76243.798.9326.06
Upgrade
Total Assets
5,4334,3763,4423,1302,9871,328
Upgrade
Accounts Payable
41.5113.255.151.753.44-
Upgrade
Accrued Expenses
129.44314.33152.6896.9693.5828.55
Upgrade
Current Portion of Long-Term Debt
-----110
Upgrade
Current Portion of Leases
1.11.431.664.72--
Upgrade
Current Income Taxes Payable
139.075.46.98-0.360.35
Upgrade
Current Unearned Revenue
0.42-0.10.18--
Upgrade
Other Current Liabilities
232.7655.6288.0452.5111.634.76
Upgrade
Total Current Liabilities
544.3390.03254.62156.12109.01143.66
Upgrade
Long-Term Leases
0.470.390.30.68--
Upgrade
Long-Term Unearned Revenue
-----0.36
Upgrade
Long-Term Deferred Tax Liabilities
21.630.14----
Upgrade
Other Long-Term Liabilities
3.653.650.20.2--
Upgrade
Total Liabilities
570.05394.22255.12156.99109.01144.02
Upgrade
Common Stock
450450450450450360
Upgrade
Additional Paid-In Capital
3,2303,1753,1003,0312,9571,043
Upgrade
Retained Earnings
1,034264.02-380.16-510.68-528.95-218.44
Upgrade
Comprehensive Income & Other
148.7993.6317.613.25--
Upgrade
Shareholders' Equity
4,8633,9823,1872,9732,8781,184
Upgrade
Total Liabilities & Equity
5,4334,3763,4423,1302,9871,328
Upgrade
Total Debt
1.571.821.965.39-110
Upgrade
Net Cash (Debt)
3,0282,5102,0352,2552,591836.98
Upgrade
Net Cash Growth
34.40%23.32%-9.73%-12.99%209.60%23055.65%
Upgrade
Net Cash Per Share
6.735.574.524.947.012.32
Upgrade
Filing Date Shares Outstanding
450450450450450360
Upgrade
Total Common Shares Outstanding
450450450450450360
Upgrade
Working Capital
3,2462,5182,0322,2192,570842.17
Upgrade
Book Value Per Share
10.818.857.086.616.403.29
Upgrade
Tangible Book Value
4,7973,9163,1192,9062,8091,116
Upgrade
Tangible Book Value Per Share
10.668.706.936.466.243.10
Upgrade
Buildings
-468.4470.35116.73116.73112.87
Upgrade
Machinery
-158.55140.2788.3475.3666.24
Upgrade
Construction In Progress
-18.5813.8266.5778.4411.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.